Kamiar AminianKamiar Aminian received the M.S. degree in electrical engineering in 1982, the Ph.D degree in biomedical engineering in 1989 and the Postgraduate degree on technical computing in 1993 from Ecole Polytechnique Fédérale de Lausanne (EPFL). He was assistant professor (1994-1996) with Sharif University of Technology (Tehran). He joint EPFL in 1996 where he is currently Professor of medical instrumentation and the director of the Laboratory of Movement Analysis and Measurement in the Institute of Bioengineering of EPFL. His research interests include methodologies for human movement monitoring and analysis in real world conditions mainly based on wearable technologies and inertial sensors with emphasis on gait, physical activity and sport. His research aims to perform outcome evaluation in orthopaedics, to improve motor function and intervention programs in aging and patients with movement disorders and pain, and to identify metrics of performance in sport science.
Kamiar Aminian is a member of the International Society of Posture and Gait Research, the Institute of Electrical and Electronics Engineers, the European Society of Movement Analysis in Adults and Children, the Prevention of fall Network Europe, the Intentional Society of Biomechanics and the President of the 3D analysis of the human movement group. He is author or co-author of more than 450 scientific papers published in reviewed journals and presented at international conferences and holds 10 patents related to medical devices.
Full CV
ORCID
Rachid GuerraouiRachid Guerraoui has been affiliated with Ecole des Mines of Paris, the Commissariat à l'Energie Atomique of Saclay, Hewlett Packard Laboratories and the Massachusetts Institute of Technology. He has worked in a variety of aspects of distributed computing, including distributed algorithms and distributed programming languages. He is most well known for his work on (e-)Transactions, epidemic information dissemination and indulgent algorithms.
He co-authored a book on Transactional Systems (Hermes) and a book on reliable distributed programming (Springer). He was appointed program chair of ECOOP 1999, ACM Middleware 2001, IEEE SRDS 2002, DISC 2004 and ACM PODC 2010.
His publications are available at http://lpdwww.epfl.ch/rachid/papers/generalPublis.html Friedrich EisenbrandFriedrich Eisenbrand's main research interests lie in the field of discrete optimization, in particular in algorithms and complexity, integer programming, geometry of numbers, and applied optimization. He is best known for his work on efficient algorithms for integer programming in fixed dimension and the theory of cutting planes, which are an important tool to solve large scale industrial optimization problems in practice.
Before joining EPFL in March 2008, Friedrich Eisenbrand was a full professor of mathematics at the University of Paderborn. Friedrich received the Heinz Maier-Leibnitz award of the German Research Foundation (DFG) in 2004 and the Otto Hahn medal of the Max Planck Society in 2001.
Willy ZwaenepoelWilly Zwaenepoel received his B.S. from the University of Gent, Belgium in 1979, and his M.S. and Ph.D. from Stanford University in 1980 and 1984, respectively. In September 2002, he joined EPFL. He was Dean of the School of Computer and Communications Sciences at EPFL from 2002 to 2011. Before joining EPFL, Willy Zwaenepoel was on the faculty at Rice University, where he was the Karl F. Hasselmann Professor of Computer Science and Electrical and Computer Engineering.
He was elected Fellow of the IEEE in 1998, and Fellow of the ACM in 2000. In 2000 he received the Rice University Graduate Student Association Teaching and Mentoring Award. In 2007 he received the IEEE Tsutomu Kanai award. He was elected to the European Academy in 2009. He won best paper awards at SigComm 1984, OSDI 1999, Usenix 2000, Usenix 2006 and Eurosys 2007. He was program chair of OSDI in 1996 and Eurosys in 2006, and general chair of Mobisys in 2004. He was also an Associate Editor of the IEEE Transactions on Parallel and Distributed Systems from 1998 to 2002.
Willy Zwaenepoel has worked in a variety of aspects of operating and distributed systems, including microkernels, fault tolerance, parallel scientific computing on clusters of workstations, clusters for web services, mobile computing, database replication and virtualization. He is most well known for his work on the Treadmarks distributed shared memory system, which was licensed to Intel and became the basis for Intels OpenMP cluster product. His work on high-performance software for network I/O led to the creation of iMimic Networking, Inc, which he led from 2000 to 2005. His current interests include large-scale data stores and software testing. Most recently, his work in software testing led to the creation of BugBuster, a startup based in Lausanne.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.